📰 Reverse Transcriptase News
Page 8 - Reverse Transcriptase News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Reverse Transcriptase. Real-time updates on events, politics, business and more.
June 10, 2021
An interesting new medRxiv* preprint reveals that with careful training, the exquisite scent sensitivity of dogs may be exploited to rule out the presence of coronavirus disease 2019 (COVID-19) in human beings in real-time.
June 3, 2021
Now a new preprint research paper posted to the bioRxiv* server dismisses the possibility, raised by that study, that the virus inserts its genetic material into the host cell’s genome.
May 29, 2021
The report titled “Reverse Transcriptase Market” has recently added by MarketInsightsReports to get a stronger and effective business outlook. It prov
May 24, 2021
Share: Newark, NJ, May 24, 2021 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global antiviral drugs market is expected to grow from USD 44.01 Billion in 2020 and to reach USD 51.67 Billion by 2028, growing at a CAGR of 2.0% during the forecast period 2021-2028. The factors driving the market are growing surge in healthcare framework payout ability, the extent of a well-established supply chain, increasing interest to brace the evolution of novel antiviral drugs, adva...
April 30, 2021
Researchers review materials used to design biosensors for SARS-CoV-2 detection The SARS-CoV-2 virus is still causing a dramatic loss of human lives worldwide, constituting an unprecedented challenge for society, public health, and economy, to overcome. Currently, SARS-CoV-2 can be diagnosed in two different ways: i) antigen tests (point-of-care, POC) and ii) molecular tests (nucleic acid, RNA, or PCR-polymerase chain reaction). Antigen tests can detect parts of SARS-CoV-2 proteins, known as an...
April 22, 2021
Metabolic testing of COVID-19 patients through skin imprints The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), shows no sign of abating soon. In fact, the recent surge of cases caused by new and potentially more lethal variants of the virus, with immune evasion capabilities, threatens to overwhelm healthcare systems in many countries, even as vaccines are being rolled out in many. There is, therefore, a great need to understand ...
April 21, 2021
Can sniffer dogs be trained to detect SARS-CoV-2 infection? All over the world, the successive and frequently larger waves of coronavirus disease 2019 (COVID-19) have made it difficult to obtain adequate supplies of the testing kits and reagents required for the gold standard of infection detection: reverse transcriptase polymerase chain reaction (RT PCR). The time required to obtain a readout of the results is also long, creating transmission hazards for those with asymptomatic infection. Mean...
April 8, 2021
2 Min Read Published on: 3 hours ago Faculty and students from Loma Linda University School of Public Health have been monitoring possible COVID-19 exposure by testing wastewater on the school campus in Loma Linda, California, United States. Ryan Sinclair, professor in the School of Public Health, has applied Wastewater Based Epidemiology (WBE) as an innovative method of surveillance. Wastewater monitoring has been used historically to track enteric viruses and other pathog...
April 5, 2021
Posted April 5th, 2021 for Pathkits Pathkits is an ICMR approved testing kits manufacturer based in India. Currently Pathkits has achieved a milestone of selling 50 Million VTM kits, and has become largest supplier in India. VTM (Viral Transport Medium) kits and becomes the largest supplier in India. Since COVID-19 drastically hit the nation, there’s been a huge demand among medical authorities and hospitals to have VTM kits to collect and transport viruses from one place to another. Alt...
March 11, 2021
email article Dolutegravir (Tivicay)-based antiretroviral therapy in children with HIV infection was superior to efavirenz-based standard of care in the first-line setting in a prospective trial, researchers reported. In her presentation at the virtual Conference on Retroviruses and Opportunistic Infections, Anna Turkova, MD, of University College London, added that in the second-line setting, it appears dolutegravir-based treatment is at least non-inferior to current treatment regimens. ...